| |
Latest 10 SEC filings (by transaction date) for HROW within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 28/24 | Mar 28/24 | Opaleye Management Inc. | Indirect Ownership | Common Stock, par value $0.001 per share | P - Open market or private purchase | 50,000 | $12.82 |
Mar 25/24 | Mar 22/24 | Baum Mark L | Direct Ownership | Common stock | P - Open market or private purchase | 9,000 | $11.59 |
Mar 22/24 | Mar 20/24 | Opaleye Management Inc. | Indirect Ownership | Common Stock, par value $0.001 per share | P - Open market or private purchase | 50,600 | $9.65 |
Mar 6/24 | Mar 1/24 | Saharek John P. | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 6/24 | Mar 1/24 | Saharek John P. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $8.75 |
Feb 21/24 | Feb 20/24 | Saharek John P. | Direct Ownership | RSU | M - Exercise or conversion exempt under rule 16b-3 | -30,000 | |
Feb 21/24 | Feb 20/24 | Saharek John P. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | -12,616 | $10.67 |
Feb 21/24 | Feb 20/24 | Saharek John P. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | 30,000 | $10.67 |
Feb 21/24 | Feb 20/24 | Boll Andrew R. | Direct Ownership | RSU | M - Exercise or conversion exempt under rule 16b-3 | -45,000 | |
Feb 21/24 | Feb 20/24 | Boll Andrew R. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | -18,480 | $10.67 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for HROW within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 28/24 | Mar 28/24 | Opaleye Management Inc. | Indirect Ownership | Common Stock, par value $0.001 per share | P - Open market or private purchase | 50,000 | $12.82 |
Mar 25/24 | Mar 22/24 | Baum Mark L | Direct Ownership | Common stock | P - Open market or private purchase | 9,000 | $11.59 |
Mar 22/24 | Mar 20/24 | Opaleye Management Inc. | Indirect Ownership | Common Stock, par value $0.001 per share | P - Open market or private purchase | 50,600 | $9.65 |
Mar 6/24 | Mar 1/24 | Saharek John P. | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,000 | |
Mar 6/24 | Mar 1/24 | Saharek John P. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | 5,000 | $8.75 |
Feb 21/24 | Feb 20/24 | Saharek John P. | Direct Ownership | RSU | M - Exercise or conversion exempt under rule 16b-3 | -30,000 | |
Feb 21/24 | Feb 20/24 | Saharek John P. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | -12,616 | $10.67 |
Feb 21/24 | Feb 20/24 | Saharek John P. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | 30,000 | $10.67 |
Feb 21/24 | Feb 20/24 | Boll Andrew R. | Direct Ownership | RSU | M - Exercise or conversion exempt under rule 16b-3 | -45,000 | |
Feb 21/24 | Feb 20/24 | Boll Andrew R. | Direct Ownership | Common stock | M - Exercise or conversion exempt under rule 16b-3 | -18,480 | $10.67 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |